twenty patients with unresectable non-small cell lung cancer were treated with a combination chemotherapy of cisplatin ( 30 mg/body i.v. , days 1-5 ) , peplomycin ( 5 or 8 mg/body continuous infusion , days 1-5 ) , mitomycin c ( 4 mg/body i.v. , day 1 ) , and vincristine ( 2 mg/body i.v. , day 1 ) , of 15 patients evaluable for response ( 9 with squamous cell carcinoma , 2 with adenocarcinoma , nd 4 with large cell carcinoma ) , the overall response rate was 46.7 % with 7 partial responses .
C0002475
mitomycin c
C0001418
adenocarcinoma